Chemoprevention of Breast Cancer: A Summary of the Evidence for the U.S. Preventive Services Task Force

Figure. Harms include endometrial cancer, stroke, and pulmonary embolism combined. Adapted from reference .
Benefits and harms of chemoprevention with tamoxifen per 10 000 women in three age groups.49
-
Ann Intern Med
July 2, 2002
vol. 137
no. 1
59-69